Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan D Manning

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Trends in Cancer|September 27, 2016
Emerging role of mTOR in the response to cancer therapeuticsErika Ilagan, Brendan D Manning
Biochemical Society Transactions|January 16, 2009
A complex interplay between Akt, TSC2 and the two mTOR complexesJingxiang Huang, Brendan D Manning
Nature|June 28, 2013
Cell signalling: nutrient sensing lost in cancerSuchithra Menon, Brendan D Manning
Science Signaling|September 26, 2013
mTORC1 status dictates tumor response to targeted therapeuticsIlana Kelsey, Brendan D Manning
Trends in Endocrinology and Metabolism: TEM|April 10, 2026
LIFe of the sugar-free party in cancer metabolismKhaled Tighanimine, Brendan D Manning
Cell|April 22, 2017
AKT/PKB Signaling: Navigating the NetworkBrendan D Manning, Alex Toker
Cell Cycle (Georgetown, Tex.)|May 29, 2015
mTORC1 signaling activates NRF1 to increase cellular proteasome levelsYinan Zhang, Brendan D Manning
Cancer Research|April 14, 2011
Transcriptional control of cellular metabolism by mTOR signalingJessica L Yecies, Brendan D Manning
Cell|January 21, 2010
Chewing the fat on tumor cell metabolismJessica L Yecies, Brendan D Manning
Science'S STKE : Signal Transduction Knowledge Environment|December 12, 2002
Hitting the target: emerging technologies in the search for kinase substratesBrendan D Manning, Lewis C Cantley
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Trends in Cancer|September 27, 2016
Emerging role of mTOR in the response to cancer therapeuticsErika Ilagan, Brendan D Manning
Biochemical Society Transactions|January 16, 2009
A complex interplay between Akt, TSC2 and the two mTOR complexesJingxiang Huang, Brendan D Manning
Nature|June 28, 2013
Cell signalling: nutrient sensing lost in cancerSuchithra Menon, Brendan D Manning
Science Signaling|September 26, 2013
mTORC1 status dictates tumor response to targeted therapeuticsIlana Kelsey, Brendan D Manning
Trends in Endocrinology and Metabolism: TEM|April 10, 2026
LIFe of the sugar-free party in cancer metabolismKhaled Tighanimine, Brendan D Manning
Cell|April 22, 2017
AKT/PKB Signaling: Navigating the NetworkBrendan D Manning, Alex Toker
Cell Cycle (Georgetown, Tex.)|May 29, 2015
mTORC1 signaling activates NRF1 to increase cellular proteasome levelsYinan Zhang, Brendan D Manning
Cancer Research|April 14, 2011
Transcriptional control of cellular metabolism by mTOR signalingJessica L Yecies, Brendan D Manning
Cell|January 21, 2010
Chewing the fat on tumor cell metabolismJessica L Yecies, Brendan D Manning
Science'S STKE : Signal Transduction Knowledge Environment|December 12, 2002
Hitting the target: emerging technologies in the search for kinase substratesBrendan D Manning, Lewis C Cantley
Pageof 11